Risk factors for primary sclerosing cholangitis

Liver International

Volumn 36, Issue 1, 2016, Pages 84-91

  Boonstra, Kirsten ^a   De vries, Elisabeth M G ^a   van Geloven, Nan ^a   Van Erpecum, Karel J ^b   Spanier, Marcel ^c   Poen, Alexander C ^d   van Nieuwkerk, Carin M ^e   Witteman, Ben J ^f   Tuynman, Hans A ^g   Naber, Anton H ^h   Kingma, Paul J ^h   Beuers, Ulrich ^a   Ponsioen, Cyriel Y ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d ISALA HOSPITAL   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f GELDERSE VALLEI HOSPITAL   (Netherlands)

^g Medical Centre Alkmaar   (Netherlands)

^h TERGOOI HOSPITAL   (Netherlands)

Author keywords

Appendectomy; Primary sclerosing cholangitis; Risk factors; Smoking

Indexed keywords

ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; APPENDECTOMY; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CROHN DISEASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILY HISTORY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLAMMATORY BOWEL DISEASE; LIVER HISTOLOGY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE; PATIENT HISTORY OF SURGERY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RISK FACTOR; SMOKING; ULCERATIVE COLITIS; URBANIZATION; CASE CONTROL STUDY; CHOLANGITIS, SCLEROSING; DEMOGRAPHY; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; PROTECTION; STATISTICS AND NUMERICAL DATA;

ADULT; APPENDECTOMY; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; DEMOGRAPHY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NETHERLANDS; PROTECTIVE FACTORS; RISK FACTORS; SMOKING;

EID: 84940705494     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12894     Document Type: Article

References (37)

1. Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013; 58: 2045–55.
2. Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 523–6.
3. Claessen MMH, Vleggaar FP, Tytgat KMAJ, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009; 50: 158–64.
4. Boonstra K, van Erpecum KJ, van Nieuwkerk KMJ, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2270–6.
5. Anderson C, Boucher G, Lees C, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to. Nat Genet 2011; 43: 246–52.
6. Karlsen TH. A lecture on the genetics of primary sclerosing cholangitis. Dig Dis 2012; 30(Suppl 1): 32–8.
7. Bergquist A, Montgomery SM, Bahmanyar S, et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2008; 6: 939–43.
8. Harries A, Jones L, Heatley R, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982; 284: 706.
9. Lindberg E, Tysk C, Andersson K, Ja€rnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988; 29: 352–7.
10. Russel MG, Dorant E, Brummer RJM, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn’s disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997; 113: 377–82.
11. Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol 2000; 95: 171–6.
12. Reif S, Lavy A, Keter D, et al. Lack of association between smoking and Crohn’s disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol 2000; 95: 474–8.
13. Naganuma M, Iizuka B, Torii A, et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001; 96: 1123–6.
14. Abraham N, Selby W, Lazarus R, Solomon M. Is smoking an indirect risk factor for the development of ulcerative colitis? An age- and sex-matched case – control study. J Gastroenterol Hepatol 2003; 18: 139–46.
15. Regueiro M, Kip KE, Hegazi RA, Plevy S. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 42–7.
16. Jiang L, Xia B, Li J, et al. Risk Factors for Ulcerative Colitis in a Chinese Population: an age-matched and sex-matched case-control study. J Clin Gastroenterol 2007; 41: 280–4.
17. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325–33.
18. Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis 2011; 5: 577–84.
19. Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: a case-control, multi-centre, prospective study in Southern Italy. J Crohns Colitis 2012; 6: 324–9.
20. Lakatos PL, Vegh Z, Lovasz BD, et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis 2013; 19: 1010–7.
21. Van Erpecum KJ, Smits SJ, van de Meeberg PC, et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology 1996; 110: 1503–6.
22. Loftus EV, Sandborn WJ, Tremaine WJ, et al. Primary sclerosing cholangitis is associated with nonsmoking; a case-control study. Gastroenterology 1996; 110: 1496–502.
23. Mitchell S, Thyssen M, Orchard T, et al. Cigarette smoking,appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut 2002; 51: 567–73.
24. Florin T, Pandeya N, Radford-Smith G. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut 2004; 53: 973–9.
25. EASL. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237–67.
26. Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 170: 16–9.
27. Andersen IM, Tengesdal G, Lie BA, et al. Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2014; 12: 1019–28.
28. Eaton JE, Juran BD, Atkinson EJ, et al. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis,with and without inflammatory bowel disease. Aliment Pharmacol Ther 2015; 41: 980–90.
29. Thomas G, Rhodes J, Ingram J. Mechanisms of disease:nicotine–a review of its actions in the context of gastrointestinal disease. Nat Clin Pr Gastroenterol Hepatol 2005; 2: 536–44.
30. van der Zanden E, Hilbers F, Verseijden C, et al. Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals. NeuroImmunoModulation 2012; 19: 255–65.
31. Soeda J, Morgan M, McKee C, et al. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochem Biophys Res Commun 2012; 417: 17–22.
32. Zein CO, Beatty K, Post AB, et al. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology 2006; 44: 1564–71.
33. Andersson T, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344: 808–14.
34. Cheluvappa R, Luo AS, Palmer C, Grimm MC. Protective pathways against colitis mediated by appendicitis and appendectomy. Clin Exp Immunol 2011; 165: 393–400.
35. Ala A, Stanca CM, Bu-Ghanim M, et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 2006; 43: 525–31.
36. Zeegers T, Zantinge E. Hoeveel mensen roken? [Internet]. In: Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. Available at http://www.nationaalkompas.nl2011. Accessed: 10 December 2010.
37. Bruggink J-W. Trends in the share of smokers in the Netherlands since 1989. Tijdschr Voor Gezondheidswetenschappen 2013; 91: 234–40.